These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1515658)

  • 1. Androgen profile in patients with pancreatic carcinoma.
    Sperti C; Bonadimani B; Guolo P; Militello C; Cappellazzo F; Pasquali C; Pedrazzoli S
    Ital J Gastroenterol; 1992; 24(6):328-31. PubMed ID: 1515658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone and androgen metabolism in pancreatic cancer.
    Sperti C; Bonadimani B; Militello C; Cappellazzo F; Pedrazzoli S; Guolo P
    J Clin Gastroenterol; 1992 Sep; 15(2):161-2. PubMed ID: 1401831
    [No Abstract]   [Full Text] [Related]  

  • 3. [Low levels of testosterone in patients with pancreatic carcinoma].
    Militello C; Sperti C; Marra S; Pasquali C; Bonadimani B; Cappellazzo F; Petrin P; Scandellari C; Pedrazzoli S
    Minerva Chir; 1988 Apr; 43(7):581-6. PubMed ID: 3140070
    [No Abstract]   [Full Text] [Related]  

  • 4. Pancreatic carcinoma and low serum testosterone; a correlation secondary to cancer cachexia?
    Todd BD
    Eur J Surg Oncol; 1988 Jun; 14(3):199-202. PubMed ID: 3371470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum prostate-specific antigen in pancreatic disease.
    Pezzilli R; Bertaccini A; Billi P; Zanarini L; Miglio F; Martorana G
    Ital J Gastroenterol Hepatol; 1999 Oct; 31(7):580-3. PubMed ID: 10604096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic cancer and androgen metabolism: high androstenedione and low testosterone serum levels.
    Fernández-del Castillo C; Robles-Díaz G; Díaz-Sánchez V; Altamirano A
    Pancreas; 1990 Sep; 5(5):515-8. PubMed ID: 2235963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C reactive protein in pancreatic cancer and chronic pancreatitis.
    Basso D; Fabris C; Meani A; Del Favero G; Vianello D; Angonese C; Meggiato T; Bellinvia S; Fogar P; Petrin P
    Ann Clin Res; 1988; 20(6):414-6. PubMed ID: 3218913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Testosterone-dihydrotestosterone ratio in the differential diagnosis of pancreatic disease].
    Sándor Z; Tulassay Z; Bodrogi L; Papp J; Szathmári M; Fehér T
    Orv Hetil; 1989 Jun; 130(26):1387-8. PubMed ID: 2748159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum testosterone:dihydrotestosterone ratio and CA 19-9 in the diagnosis of pancreatic cancer.
    Robles-Díaz G; Díaz-Sánchez V; Fernández-del Castillo C; Morales M; Aceves G; Galván E; Altamirano A
    Am J Gastroenterol; 1991 May; 86(5):591-4. PubMed ID: 2028950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal predictors of prostate cancer.
    Sofikerim M; Eskicorapci S; Oruç O; Ozen H
    Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum soluble interleukin-2 receptor in pancreatic cancer and chronic pancreatitis.
    Pezzilli R; Billi P; Beltrandi E; Mancini R; Casadei-Maldini M; Casadei R; Greco VM; Campione O; Miglioli M
    Ital J Gastroenterol; 1994 Apr; 26(3):137-40. PubMed ID: 8061340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen levels in the third trimester of pregnancy in patients with preeclampsia.
    Salamalekis E; Bakas P; Vitoratos N; Eleptheriadis M; Creatsas G
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):16-9. PubMed ID: 16139944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CA 50 compared with CA 19-9 as a serum tumour marker for pancreatic carcinoma.
    Pasquali C; Sperti C; D'Andrea AA; Costantino V; Filipponi C; Pedrazzoli S
    Ital J Gastroenterol; 1994 May; 26(4):169-73. PubMed ID: 7949259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low serum testosterone/dihydrotestosterone ratio in patients with pancreatic carcinoma.
    Robles-Diaz G; Diaz-Sanchez V; Mendez JP; Altamirano A; Wolpert E
    Pancreas; 1987; 2(6):684-7. PubMed ID: 3438305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of direct and indirect markers to assess the androgen status in healthy males during aging.
    Elmlinger MW; Kühnel W; Döller PC
    Clin Lab; 2006; 52(9-10):491-6. PubMed ID: 17078476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women with low libido: correlation of decreased androgen levels with female sexual function index.
    Turna B; Apaydin E; Semerci B; Altay B; Cikili N; Nazli O
    Int J Impot Res; 2005; 17(2):148-53. PubMed ID: 15592425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tract.
    Hejna M; Hamilton G; Brodowicz T; Haberl I; Fiebiger WC; Scheithauer W; Virgolini I; Köstler WJ; Oberhuber G; Raderer M
    Anticancer Res; 2001; 21(2A):1183-7. PubMed ID: 11396161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of serum TAG-72 as a tumor marker for pancreatic carcinoma. Comparison with CA 19-9.
    Pasquali C; Sperti C; D'Andrea AA; Costantino V; Filipponi C; Pedrazzoli S
    Int J Pancreatol; 1994 Jun; 15(3):171-7. PubMed ID: 7930777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between androgen levels and premature coronary artery disease in men.
    Turhan S; Tulunay C; Güleç S; Ozdöl C; Kilickap M; Altin T; Gerede M; Erol C
    Coron Artery Dis; 2007 May; 18(3):159-62. PubMed ID: 17429287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subnormal androgen levels in young female bone marrow transplant recipients with ovarian dysfunction, chronic GVHD and receiving glucocorticoid therapy.
    Hovi L; Saarinen-Pihkala UM; Taskinen M; Wikström AM; Dunkel L
    Bone Marrow Transplant; 2004 Mar; 33(5):503-8. PubMed ID: 14716348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.